David Nichols

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About David Nichols

David Nichols was last confirmed as Board Member at Dianthus Therapeutics, Inc. /DE/ (DNTH) in a filing dated May 2, 2022. The proxy statement of Dianthus Therapeutics, Inc. /DE/ reports total compensation of $1,661,676 for David Nichols in fiscal 2021, including a base salary of $246,591.

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Explain David Nichols's disclosed executive compensation over time and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Dianthus Therapeutics, Inc. /DE/ (DNTH)
Board Member

Proxy statement

Start not stated–2022-05-02

Last confirmed by a filing; no departure on record
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Proxy statement

Start not stated–2021-04-21

Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Dianthus Therapeutics, Inc. /DE/

DNTH

Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2021	Dianthus Therapeutics, Inc. /DE/ (DNTH)	Chief Technical Officer	$246,591	$40,000	—	$1,272,752	$98,000	$4,333	$1,661,676

Recent activity

No call appearances or filed executive changes recorded yet.